Inventor
EBERSBACH HILMAR ERHARD
CH8 patents
⚠️ This page may combine multiple inventors who share the name “EBERSBACH HILMAR ERHARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
7 patentsUS10174095B2Jan 8, 2019
Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor
NOVARTIS AG41 citations96
US9777061B2Oct 3, 2017
Treatment of cancer using a CD33 chimeric antigen receptor
NOVARTIS AG85 citations96
US11084880B2Aug 10, 2021
Anti-BCMA chimeric antigen receptor
NOVARTIS AG15 citations93
US10568947B2Feb 25, 2020
Treatment of cancer using a CLL-1 chimeric antigen receptor
NOVARTIS AG6 citations71
US12338287B2Jun 24, 2025
Treatment of cancer using a CD33 chimeric antigen receptor
NOVARTIS AG0 citations61
US11459390B2Oct 4, 2022
Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chimeric antigen receptor
NOVARTIS AG0 citations61
US10851166B2Dec 1, 2020
Treatment of cancer using a CD33 chimeric antigen receptor
NOVARTIS AG1 citations61